seri
patient
probabl
sar
diagnos
criteria
treat
accord
treatment
protocol
consist
antibacteri
combin
ribavirin
methylprednisolon
experi
first
patient
abl
finalis
standard
dose
regimen
includ
puls
methylprednisolon
one
patient
recov
antibacteri
treatment
alon
show
rapid
sustain
respons
achiev
improv
stepup
puls
methylprednisolon
four
patient
requir
short
period
noninvas
ventil
patient
requir
intub
mechan
ventil
mortal
treatment
morbid
seri
sever
acut
respiratori
syndrom
sar
emerg
infecti
diseas
associ
novel
coronaviru
caus
worldwid
outbreak
two
larg
seri
clinic
laboratori
radiolog
microbiolog
find
analys
treatment
strategi
remain
divers
experiment
without
uniform
effect
describ
continu
prospect
studi
develop
standard
treatment
protocol
preliminari
outcom
march
march
clinic
compat
sar
patient
admit
pamela
youd
nethersol
eastern
hospit
hong
kong
among
could
trace
index
case
admit
march
die
march
case
definit
fever
higher
present
previou
day
without
chill
rigor
influenzalik
symptom
new
radiolog
infiltr
compat
pneumonia
contact
histori
exclus
preexist
infect
lung
disord
aspir
hospitalacquir
bacteri
pneumonia
case
fulfil
criteria
probabl
sar
case
current
time
laboratori
investig
includ
haematolog
complet
blood
count
differenti
clot
profil
biochem
electrolyt
liver
renal
function
creatin
kinas
lactat
dehydrogenas
microbiolog
test
exclud
caus
pathogen
bacteri
cultur
blood
sputum
urin
serolog
microagglutin
mycoplasma
legionella
serolog
direct
immunofluoresc
chlamydia
influenza
parainfluenza
respiratori
syncyti
adenovirus
nasopharyng
aspir
viral
cell
cultur
direct
sputum
smear
pneumocysti
carinii
silver
stain
chest
radiograph
semiquantifi
separ
lung
six
section
upper
middl
lower
zone
medial
later
divis
score
fourpoint
scale
clear
subtl
hazi
mild
infiltr
groundglass
appear
promin
infiltr
confluent
dens
opac
three
respirologist
score
chest
radiograph
independ
consensu
decid
case
discord
launch
initi
protocol
march
consist
combin
treatment
broadspectrum
antivir
immunomodul
agent
antibacteri
institut
exclus
recognis
pathogen
acut
viral
infect
may
produc
damag
host
cell
cytolysi
immunopatholog
damag
earli
stage
cytolysi
accompani
viral
amplif
develop
standard
treatment
protocol
sever
acut
respiratori
syndrom
loletta
ky
arthur
c
w
lau
loretta
c
yam
thoma
cheung
edwin
poon
raymond
w
h
yung
k
yuen
standard
treatment
protocol
sar
suspect
probabl
adult
patient
antibacteri
treatment
q
start
levofloxacin
mg
daili
intraven
oral
q
clarithromycin
mg
twice
daili
oral
plu
coamoxiclav
amoxicillin
clavulan
acid
mg
three
time
daili
oral
patient
year
pregnant
suspect
tuberculosi
add
combin
treatment
ribavirin
methylprednisolon
q
extens
bilater
chest
radiograph
involv
q
persist
chest
radiograph
involv
persist
high
fever
day
q
clinic
chest
radiograph
laboratori
find
suggest
worsen
q
oxygen
satur
room
air
standard
corticosteroid
regimen
day
q
methylprednisolon
mgkg
everi
h
mgkg
daili
intraven
day
q
methylprednisolon
mgkg
everi
h
mgkg
daili
intraven
day
q
prednisolon
mgkg
twice
daili
mgkg
daili
oral
day
q
prednisolon
mgkg
daili
oral
day
q
prednisolon
mgkg
daili
oral
day
q
ribavirin
regimen
day
q
ribavirin
mg
everi
h
mg
daili
intraven
least
day
condit
becom
stabl
q
ribavirin
mg
twice
daili
mg
daili
oral
puls
methylprednisolon
q
give
puls
methylprednisolon
clinic
condit
chest
radiograph
oxygen
satur
worsen
least
two
lymphopenia
persist
q
give
methylprednisolon
mg
twice
daili
intraven
day
back
standard
corticosteroid
regimen
ventil
q
consid
noninvas
ventil
mechan
ventil
oxygen
satur
l
per
min
oxygen
patient
complain
increas
short
breath
condit
increas
chang
per
h
two
exhaust
ventil
fan
instal
cubicl
achiev
negativepressur
airflow
closedsystem
suction
use
mechan
ventil
tube
fit
higheffici
particul
air
similar
filter
healthcar
worker
wore
surgic
mask
protect
eyewear
fullfac
shield
cap
gown
full
sleev
coverag
surgic
glove
shoe
cover
advanc
barrier
airmat
hepa
power
air
purifi
respir
system
mn
usa
person
protect
system
stryker
instrument
mi
usa
stock
case
highrisk
procedur
endotrach
intub
requir
staff
wash
hand
antisept
rub
everi
contact
patient
contamin
object
take
protect
garment
direct
contact
eye
nose
mouth
hand
sanitis
discourag
environment
equip
surfac
clean
daili
immedi
use
domest
bleach
ppm
hypochlorit
solut
nonmetal
item
alcohol
metal
item
treat
chines
resid
men
mean
age
year
sd
four
patient
smoker
one
comorbid
diabet
mellitu
hypertens
coronari
arteri
diseas
clinic
laboratori
featur
describ
earlier
report
overal
present
symptom
includ
pyrexia
chill
rigor
malais
anorexia
cough
myalgia
headach
dyspnoea
diarrhoea
mean
temperatur
puls
beat
per
min
respiratori
antivir
may
import
treatment
later
stage
adapt
immun
respons
mount
viral
clearanc
accompani
sever
inflammatori
damag
especi
high
viral
burden
immunomodul
agent
corticosteroid
could
reduc
tissu
damag
antivir
chose
ribavirin
potenc
dna
rna
virus
methylprednisolon
achiev
immunomodul
dose
wean
schedul
methylprednisolon
modifi
accord
experi
treat
first
patient
index
case
index
case
fatal
outcom
suggest
late
administr
combin
treatment
probabl
ineffect
patient
heavier
bodyweight
worsen
despit
intraven
mg
methylprednisolon
everi
h
correct
bodyweight
mgkg
daili
result
lower
fever
radiograph
improv
day
patient
fever
worsen
thereaft
therefor
increas
initi
methylprednisolon
dose
mgkg
daili
sever
sever
case
continu
worsen
requir
puls
methylprednisolon
final
sinc
stepdown
methylprednisolon
dose
day
result
rebound
sar
patient
dose
level
continu
day
finalis
treatment
protocol
march
panel
also
implement
stringent
infect
control
measur
keep
minimum
droplet
spread
possibl
contact
patient
secret
fluid
excreta
patient
suspect
probabl
sar
convalesc
case
put
isol
cubicl
accommod
four
six
patient
visit
allow
arapid
sustain
respons
ribavirin
methylprednisolon
mgkg
daili
bextens
diseas
requir
earli
puls
methylprednisolon
achiev
respons
cearli
step
methylprednisolon
dose
result
rebound
sar
patient
respond
later
puls
methylprednisolon
rate
breath
per
min
oxygen
satur
common
present
laboratori
find
lymphopenia
l
thrombocytopenia
l
rais
lactat
dehydrogenas
iul
patient
chestradiograph
abnorm
admiss
bilater
upper
middl
lower
zone
respect
featur
subtl
hazi
ground
glass
appear
dens
opac
total
mean
chest
radiographi
score
follow
patient
mean
day
patient
requir
combin
treatment
mean
day
admiss
day
symptom
onset
one
patient
seroposit
novel
coronaviru
viral
rna
nasopharyng
aspir
recov
levofloxacin
alon
rapid
within
day
sustain
respons
combin
treatment
evid
patient
figur
remain
two
requir
stepup
methylprednisolon
dose
receiv
puls
methylprednisolon
sever
diseas
figur
rebound
rapid
stepdown
methylprednisolon
dose
figur
patient
requir
oxygen
four
requir
short
period
day
noninvas
ventil
cm
h
expiratori
pressur
patient
requir
intub
mechan
ventil
death
occur
sinc
start
use
treatment
protocol
attribut
death
index
case
late
diagnosi
treatment
conform
subsequ
standard
protocol
high
dose
corticosteroid
produc
sever
complic
although
prophylact
antibiot
piperacillin
tazobactam
given
seven
patient
fever
rais
white
cell
count
recov
neg
bacteri
cultur
ribavirin
led
complic
despit
known
advers
effect
haemolysi
arrhythmia
emerg
diseas
frequent
rapid
deterior
inclus
control
patient
possibl
ethic
futur
control
studi
may
abl
shed
light
efficaci
treatment
protocol
l
ky
c
w
lau
design
studi
treatment
protocol
develop
c
w
lau
l
ky
cheung
l
c
yam
data
collect
done
l
ky
c
w
lau
e
poon
data
analys
c
w
lau
l
ky
l
ky
c
w
lau
wrote
report
review
investig
k
yuen
r
w
h
yung
provid
microbiolog
infect
control
advic
l
c
yam
coordin
whole
studi
transient
myeloid
disord
uniqu
selfregress
neoplasia
specif
syndrom
transcript
factor
need
normal
growth
matur
erythroid
cell
megakaryocyt
mutat
report
acut
megakaryoblast
leukaemia
syndrom
aim
investig
chang
patient
syndrom
either
transient
myeloid
disord
acut
megakaryoblast
leukaemia
record
mutat
elimin
exon
patient
transient
myeloid
disord
age
day
acut
megakaryoblast
leukaemia
age
month
rang
mutat
differ
patient
disord
patient
transient
myeloid
disord
mutat
regress
spontan
complet
remiss
mutat
necessarili
predict
later
acut
megakaryoblast
leukaemia
lancet
transient
myeloid
disord
selfregress
myeloprolif
disord
aris
mainli
babi
syndrom
first
week
life
affect
mani
neonat
syndrom
could
therefor
provid
valuabl
insight
cellular
mechan
could
exploit
control
prolifer
outsid
convent
therapeut
approach
wechsler
colleagu
note
acquir
mutat
erythroidmegakaryocyt
lineagespecif
transcript
factor
genom
dna
sampl
six
six
patient
syndrom
acut
megakaryoblast
leukaemia
none
control
mutat
acquir
dna
remiss
sampl
chang
result
prematur
translat
termin
elimin
activ
domain
encod
exon
without
examin
patient
transient
myeloid
disord
understand
dysfunct
primari
permiss
event
second
hit
import
emerg
fulli
develop
leukaemia
thu
aim
investig
mutat
tissu
sampl
patient
syndrom
transient
myeloid
disord
analys
exon
revers
transcript
pcr
rtpcr
directli
rna
present
sampl
patient
sampl
surplu
archiv
clinic
